HTB homepage • Conference reports • Articles by subject • Subscribe October 2009 Contents Editorial Volume 10 Number 9/10 September/October 2009 Conference reports 5th IAS Conference on HIV Pathogenesis, Treatment and Prevention, 19-23 July 2009, Cape Town First results of new integrase compound: GSK1349572 Raltegravir in treatment-naive patients Nevirapine vs atazanavir/ritonavir in treatment-naive patients: ARTEN study Darunavir/r monotherapy studies Maraviroc results similar to efavirenz when analysed using more sensitive tropism test Lipid and metabolic changes with ARV combinations Maximal suppression achieved with three drugs: no additional virological impact of raltegravir intensification Tenofovir and renal safety Time from seroconversion to treatment in Europe and Africa Pharmacokinetics of atazanavir/ritonavir during pregnancy Presentation with late stage HIV in women diagnosed during pregnancy Low transmission rates and favourable pregnancy outcomes reported in the DREAM study Pregnancy rates and outcomes among women in the DART trial Pregnancy outcomes in HAART exposed infants in Johannesburg Efavirenz conceptions in Soweto Impact of regimen and duration of therapy on risk of mother-to-child HIV transmission in Johannesburg A cost-effectiveness analysis of the OCTANE trial The PEARL study Results from HSV-2 acyclovir studies Overview of TB-related studies at IAS Antiretrovirals CD4 responses after viral suppression for more than 7 years on HAART Raltegravir approved in Europe for treatment-naive patients 50mg and 100mg ritonavir doses achieve similar levels of saquinavir in Thai patients Etravirine (Intelence) label change in the US due to severe hypersensitivity reactions PK and drug interactions Raltegravir trough levels reduced by etravirine may require use of TDM Lopinavir/r affects PK exposure of some antimalarial drugs Darunavir/r increases exposure to nevirapine Interaction between Ginkgo biloba and efavirenz Use of raltegravir in HIV-positive transplant recipients Basic science and immunology Trends in Immunology: free access issue on immune senescence Low viral loads in elite controllers Immune surveillance below the radar: study offers explanation for acyclovir’s failure to reduce HIV risk Low-level HIV replication versus latency: identifying the source of viral rebounds during treatment interruption BHIVA news Detention and removal of HIV-positive people in the UK Correspondence Letter: comment on swine flu algorithm On the web 5th IAS Conference on HIV Pathogenesis, Treatment and Prevention abstracts Access to HCV treatment in Eastern Europe Guide to HIV and hepatitis B coinfection TAG pipeline report New TB website and resource HIV and the kidneys Video news: online resource PDFs Volume 10 Number 9/10 September/October 2009 PDF HTB homepage • Conference reports • Articles by subject • Subscribe